Prenatal determination of genotypes kell and cellano in at-risk pregnancies

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 42, Issue 6, 1997, Pages 353-357

  Spence, W Christine ^a,b   Maddalena, Anne ^a,b   Demers, Daniel B ^a,b   Bick, David P ^a,b  

^a GENETICS AND IVF INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genotype; Kell blood group system; Polymerase chain reaction; Prenatal diagnosis

Indexed keywords

DNA;

AMNION FLUID; ARTICLE; BLOOD GROUP KELL SYSTEM; BLOOD GROUP SYSTEM; CHORION VILLUS; DNA DETERMINATION; EARLY DIAGNOSIS; FETUS; GENE AMPLIFICATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

AMNIOTIC FLUID; CHORIONIC VILLI SAMPLING; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROBLASTOSIS, FETAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INFANT, NEWBORN; KELL BLOOD-GROUP SYSTEM; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS;

EID: 0030787899     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Marsh WL, Redman CM: The Kell blood group system: A review. Transfusion 1990;30:158-167
2. 450 value in amniotic fluid. Obstet Gynecol 1982;60: 746-749
3. Bowman JM, Pollock JM, Manning FA, et al: Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79: 239-244
4. Bowman JM, Harman FA, Manning CR, et al: Erythroblastosis fetalis produced by anti-k. Vox Sang 1989;56:187-189
5. Caine ME, Mueller-Heubach E: Kell sensitization in pregnancy. Am J Obstet Gynecol 1986;154:85-90
6. Duguid JKM, Bromilow IM: Haemolytic disease of the newborn due to anti-k. Vox Sang 1990;58:69
7. Farrr V, Gray E: Pregnancy outcome in mothers who develop Kell antibodies. Scot Med J 1988;33:300-303
8. Leggat HM, Gibson JM, Barron SL, et al: Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991;98:162-165
9. Mayne KM, Bowell PJ, Pratt GA: The significance of anti-Kell in pregnancy. Clin Lab Haematol 1990;12:379-385
10. Wenk RE, Goldstein P, Felix JK: Kell alloimmunization, hemolytic disease of the newborn, and perinatal management. Obstet Gynecol 1985;66:473-476
11. Lee S, Wu X, Reid M, et al: Molecular basis of the Kell (K1) phenotype. Blood 1995;85:912-916
12. Buscaglia M, Ghisoni L, Bellotti M, et al: Percutaneous umbilical blood sampling: Indication changes and procedure loss rate in a nine years' experience. Fetal Diagn Ther 1996; 11:106-113
13. Lee S, Zambas ED, Marsh WL, et al: Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci USA 1991;88:6353-6357
14. Lee S, Bennett PR, Overton T, et al: Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 1996;175:455-479
15. Walsh PS, Metzger DA, Higuchi R: Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991;10:506-513
16. Kazazian HH: Use of PCR in the diagnosis of monogenic disease. In PCR Technology: Principles and Applications for DNA Amplification. Edited by HA Erlich. New York, Stockholm Press, 1989, pp 166-167
17. Spence WC, Maddalena A, Demers DB, et al: Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease. Obstet Gynecol 1995;85:296-298
18. Spence WC, Potter P, Maddalena A, et al: DNA-based prenatal determination of the RhEe genotype. Obstet Gynecol 1995;86:670-672